House stock trades/20027936-036
U.S. House PTR · Texas District 32

Julie Johnson

Sale (partial) · Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

February 12, 2025$1,001 - $15,000Document 20027936
Direct answer

What did this PTR report?

SALE (PARTIAL)

Julie Johnson reported a sale (partial) involving Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) (source ticker REGN) on February 12, 2025. The source reports $1,001 - $15,000.

Open official PDF page 5
Verified source fields

Transaction record

Filer
Julie Johnson
House district
TX32
Asset
Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
Official asset type
ST · Stocks (including ADRs)
Source ticker
REGN
Transaction code
S (partial) · Sale (partial)
Transaction date
February 12, 2025
Notification date
March 6, 2025
Reported value
$1,001 - $15,000
Owner field
Joint
Filing status
New
PDF location
Page 5 · row 2
Source context

Notes printed with this row

Subholding of
Merrill Lynch Tax Efficient Core
Interpretation boundary

A reported transaction is not a verdict.

THIS PAGE CAN SAY

The filer, asset text, codes, dates, amount label, filing status, and notes above appear in the fingerprinted official PTR at the cited page.

THIS PAGE CANNOT SAY

A disclosed transaction is not evidence of wrongdoing, material nonpublic information, intent, profit, loss, investment performance, a current holding, net worth, or a conflict of interest. Most dollar values are disclosure ranges, not exact transaction amounts. Some amended official rows contain an exact dollar value; amount_is_exact distinguishes those rows. Numeric bounds are derived only from an unambiguous source value and the original label is always retained.